Heiss K F, Clark R H
Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Crit Care Med. 1995 Nov;23(11):1915-9. doi: 10.1097/00003246-199511000-00019.
To determine if data collected by the Extracorporeal Life Support Organization Registry could be used to identify neonates with congenital diaphragmatic hernia who had a > 90% mortality rate, despite the use of extracorporeal membrane oxygenation (ECMO) support.
We retrospectively reviewed data reported to the Extracorporeal Life Support Organization Registry on neonates with congenital diaphragmatic hernia.
Data regarding 1,089 neonates with congenital diaphragmatic hernia reported to the Extracorporeal Life Support Organization Registry between 1980 and 1992 formed the basis of this study. All of the neonates studied had been treated with ECMO. This patient population includes neonates with right- and left-sided diaphragmatic hernia. This registry does not include neonates with congenital diaphragmatic hernia who were not treated with ECMO.
Of 1,089 neonates with congenital diaphragmatic hernia, 679 (62%) survived. There were no differences between the two groups in gender or in the year they were treated. Survival rate did not significantly increase over the years between 1980 and 1992. When compared with survivors, nonsurvivors were more immature (38 +/- 2 vs. 39 +/- 2 wks; p = .01), had lower birth weights (3.0 +/- 0.5 vs. 3.21 +/- 0.53 kg; p = .001), were more often prenatally diagnosed (42% vs. 32%; p = .03), were cannulated at a younger age (31 +/- 54 vs. 40 +/- 50 hrs; p = .01), and had more severe respiratory compromise (higher peak pressures and PaCO2, lower PaO2 values). Multivariate analysis showed that arterial pH and PaO2 just before ECMO, and birth weight, had the highest discriminant coefficients. By using these variables in a discriminant function (D[fx] = 0.68 x pH + 0.62 x birth weight + 0.29 x PaO2; using standardized coefficients and variables), we could identify neonates who died with a sensitivity of 62%, a specificity of 63%, a positive-predictive value of 50%, and a negative-predictive value of 74%. No single variable or combination of variables yielded better results.
Although a number of factors identify neonates with diaphragmatic hernia as being at higher risk of dying despite ECMO support, data currently collected by the neonatal Extracorporeal Life Support Organization Registry do not allow clinicians to effectively discriminate nonsurvivors from survivors.
确定体外生命支持组织登记处收集的数据是否可用于识别尽管使用了体外膜肺氧合(ECMO)支持但死亡率仍>90%的先天性膈疝新生儿。
我们回顾性分析了向体外生命支持组织登记处报告的先天性膈疝新生儿的数据。
1980年至1992年间向体外生命支持组织登记处报告的1089例先天性膈疝新生儿的数据构成了本研究的基础。所有研究的新生儿均接受了ECMO治疗。该患者群体包括右侧和左侧膈疝的新生儿。该登记处不包括未接受ECMO治疗的先天性膈疝新生儿。
1089例先天性膈疝新生儿中,679例(62%)存活。两组在性别或治疗年份方面无差异。1980年至1992年间,存活率没有显著提高。与幸存者相比,非幸存者更不成熟(38±2周对39±2周;p = 0.01),出生体重更低(3.0±0.5 kg对3.21±0.53 kg;p = 0.001),更常为产前诊断(42%对32%;p = 0.03),插管时年龄更小(31±54小时对40±五十小时;p = 0.01),并且有更严重的呼吸功能不全(更高的峰值压力和PaCO2,更低的PaO2值)。多变量分析表明,ECMO前的动脉pH值和PaO2以及出生体重具有最高的判别系数。通过在判别函数中使用这些变量(D[fx]=0.68×pH + 0.62×出生体重 + 0.29×PaO2;使用标准化系数和变量),我们可以识别出死亡的新生儿,其敏感性为62%,特异性为63%,阳性预测值为50%,阴性预测值为74%。没有单一变量或变量组合能产生更好的结果。
尽管有许多因素表明先天性膈疝新生儿在接受ECMO支持时死亡风险更高,但目前新生儿体外生命支持组织登记处收集的数据不允许临床医生有效地区分非幸存者和幸存者。